LLY

MKT CAP:$965B

Eli Lilly and Company

Market Cap

$965B

Healthcare·Drug Manufacturers - General·🇺🇸 United States·NYSE

Healthcare·Drug Mfg.·🇺🇸·NYSE

Stock Price

$1,149.15+$72.44 (+6.73%)

Jun 8, 2026

52W High $1,149.1552W Low $621.26

Company Details

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Huma...

CEO

—

IPO Date

Jan 13, 1978

Website

www.lilly.com

Key Metrics TTM

Revenue

$72.2B

+47.4% YoY

Net Income

$25.3B

EPS (Diluted)

Free Cash Flow

$13.6B

Revenue / Share

$80.64

Gross Margin

83.5%

Operating Margin

45.9%

Net Margin

35.0%

FCF Margin

18.8%

P/S

13.4x

P/E

38.2x

Earnings Reports

Q2 2026

Aug 5, 2026

PENDING

Q1 2026

Apr 30, 2026

$19.8B+55.5%

FY 2025

Feb 12, 2026

$65.2B+44.7%

Q4 2025

Feb 12, 2026

$19.3B+42.6%

Q3 2025

Oct 30, 2025

$17.6B+53.9%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee